Method for inhibiting hyperpigmentation
AssigneeThe Trustees of Columbia University in the City of New York
InventorB. Jack Longley
Life of this patent
Estimating the term…
Abstract
This invention provides a method of preventing or treating in a subject contact dermatitis which comprises administering to the subject an amount of a compound capable of inhibiting the stem cell factor signaling pathway effective to prevent or treating contact dermatitis so as to thereby prevent or treat contact dermatitis in the subject. This invention also provides a method of preventing or treating in a subject hyperpigmentation, asthma, cutaneous inflammation, anaphylaxis and bronchospasm, mastocytosis, tumors which express activated kit, and conception.
Claims19
A method of preventing or treating in a subject hyperpigmentation which comprises administering to the subject an amount of a compound which inhibits, the stem cell factor signaling pathway effective to prevent or treat hyperpigmentation so as to thereby prevent or treat hyperpigmentation in the subject wherein the compound inhibits a kinase enzymatic reaction of kit protein of the stem cell factor signaling pathway.
The method of claim, wherein the anti-kit antibody is ACK2.
Dependencies are inferred from the claim text.